Recruiting NCT07643610
BEAT-SHOCK Registry
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: no internvention.
- Who it may be relevant to
- Registry conditions: Cardiogenic Shock, Myocardial Infarction (MI), Fulminant Myocarditis, Acute Decompensated Heart Failure. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Switzerland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
BEAT-SHOCK (Basel Evaluation of Acute Therapy in Cardiogenic SHOCK) Registry
Overview
This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.
Interventions
- Other no internvention
This is a health data registry.
Primary outcome measures
- In-Hospital all-cause mortality occurring before discharge from the participating study centre [Time frame: 10 years]
Secondary outcome measures (3)
- 30-day and 90-day all-cause Mortality [Time frame: 30, 90 days]
- Need for organ support at any time during hospitalization [Time frame: 30, 60, 360 days]
- Acute kidney injury (AKI) within 36 hours after index diagnosis of cardiogenic shock/index presentation [Time frame: Within 36 hours after index diagnosis of cardiogenic shock/ index presentation.]
Eligibility criteria
- Patients admitted with cardiogenic shock to the University hospital Basel (diagnosis at the time of admission) or development of cardiogenic shock during the hospital stay
- Age ≥18 years
- Provision of written ICF
- Clinical diagnosis of cardiogenic shock.
- impaired organ perfusion due to primary cardiac dysfunction,
- persistent systolic blood pressure (SBP) <90 mmHg for ≥30 minutes, or the need for vasopressors, inotropes, or mechanical circulatory support (MCS) to maintain adequate perfusion and
- evidence of systemic hypoperfusion with arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l and ≥1 of the following:
- Cold or clammy extremities
- Altered mental status
- Reduced urine output
- Signs of volume overload or congestion (on clinical exam, imaging, or invasive monitoring)
- Patients with normotensive cardiogenic shock (SBP ≥90 mmHg without vasopressors or MCS) may also be included if clear signs of hypoperfusion (arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l) and cardiac dysfunction are present and alternative causes are excluded
Exclusion criteria
- Age <18 years
- Refusal to provide informed consent by the patient or their legally authorized representative
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Switzerland · 1 center
- University Hospital Basel — Basel
Identifiers
NCT: NCT07643610 · BEAT SHOCK